First Wave BioPharma Inc
NASDAQ:ENTO

Watchlist Manager
First Wave BioPharma Inc Logo
First Wave BioPharma Inc
NASDAQ:ENTO
Watchlist
Price: 2.98 USD 16.86% Market Closed
Market Cap: 10m USD

Net Margin
First Wave BioPharma Inc

0%
Current
0%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-17.4m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

First Wave BioPharma Inc
Glance View

Market Cap
10m USD
Industry
Biotechnology

First Wave Biopharma, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of non-systemic therapies for the treatment of gastrointestinal diseases. The company is headquartered in Boca Raton, Florida and currently employs 17 full-time employees. The company went IPO on 2016-10-11. The firm is focused on developing its pipeline of gut-restricted GI clinical product candidates, including niclosamide, which is an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, which is a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. The firm is advancing two separate clinical programs of niclosamide formulations, both of which are in Phase II clinical trials, including FW-COV for Severe Acute Respiratory Syndrome Coronavirus 2 GI infections, and FW-UP for ulcerative proctitis and ulcerative proctosigmoiditis. The adrulipase programs is focused on the development of an oral, non-systemic, biologic capsule for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis and chronic pancreatitis.

ENTO Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-17.4m
/
Revenue
0
What is the Net Margin of First Wave BioPharma Inc?

Based on First Wave BioPharma Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top